New Results
Nitroxoline as a promising alternative drug for the treatment of Lyme disease based on an in-vitro study
View ORCID ProfileHector S. Alvarez-Manzo, View ORCID ProfileYumin Zhang, Wanliang Shi, Ying Zhang
doi: https://doi.org/10.1101/2021.02.04.429852
Hector S. Alvarez-Manzo
1Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA; (H.S.A.-M.); (YM.Z.); (W.S.); (H.S.A.-M.); (YM.Z.); (W.S.)
Yumin Zhang
1Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA; (H.S.A.-M.); (YM.Z.); (W.S.); (H.S.A.-M.); (YM.Z.); (W.S.)
Wanliang Shi
1Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA; (H.S.A.-M.); (YM.Z.); (W.S.); (H.S.A.-M.); (YM.Z.); (W.S.)
Ying Zhang
2State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China

Article usage
Posted February 05, 2021.
Nitroxoline as a promising alternative drug for the treatment of Lyme disease based on an in-vitro study
Hector S. Alvarez-Manzo, Yumin Zhang, Wanliang Shi, Ying Zhang
bioRxiv 2021.02.04.429852; doi: https://doi.org/10.1101/2021.02.04.429852
Subject Area
Subject Areas
- Biochemistry (10771)
- Bioengineering (8031)
- Bioinformatics (27246)
- Biophysics (13959)
- Cancer Biology (11108)
- Cell Biology (16026)
- Clinical Trials (138)
- Developmental Biology (8770)
- Ecology (13265)
- Epidemiology (2067)
- Evolutionary Biology (17337)
- Genetics (11678)
- Genomics (15902)
- Immunology (11011)
- Microbiology (26031)
- Molecular Biology (10625)
- Neuroscience (56448)
- Paleontology (417)
- Pathology (1729)
- Pharmacology and Toxicology (2999)
- Physiology (4539)
- Plant Biology (9614)
- Synthetic Biology (2682)
- Systems Biology (6967)
- Zoology (1508)